The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palmowski, M. J.
Right arrow Articles by Cerundolo, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palmowski, M. J.
Right arrow Articles by Cerundolo, V.
The Journal of Immunology, 2006, 177: 983-990.
Copyright © 2006 by The American Association of Immunologists

Role of Immunoproteasomes in Cross-Presentation1

Michael J. Palmowski*, Uzi Gileadi*, Mariolina Salio*, Awen Gallimore*, Maggie Millrain{dagger}, Edward James{dagger}, Caroline Addey{dagger}, Diane Scott{dagger}, Julian Dyson{dagger}, Elizabeth Simpson{dagger} and Vincenzo Cerundolo*,2

* Tumour Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom; and {dagger} Transplantation Biology Group, Clinical Sciences Centre, Imperial College, Hammersmith Hospital, London, United Kingdom

The evidence that proteasomes are involved in the processing of cross-presented proteins is indirect and based on the in vitro use of proteasome inhibitors. It remains, therefore, unclear whether cross-presentation of MHC class I peptide epitopes can occur entirely within phagolysosomes or whether it requires proteasome degradation. To address this question, we studied in vivo cross-presentation of an immunoproteasome-dependent epitope. First, we demonstrated that generation of the immunodominant HY Uty246–254 epitope is LMP7 dependent, resulting in the lack of rejection of male LMP7-deficient (LMP7–/–) skin grafts by female LMP7–/– mice. Second, we ruled out an altered Uty246–254-specific T cell repertoire in LMP7–/– female mice and demonstrated efficient Uty246–254 presentation by re-expressing LMP7 in male LMP7–/– cells. Finally, we observed that LMP7 expression significantly enhanced cross-priming of Uty246–254-specific T cells in vivo. The observations that male skin grafts are not rejected by LMP7–/– female mice and that presentation of a proteasome-dependent peptide is not efficiently rescued by alternative cross-presentation pathways provide strong evidence that proteasomes play an important role in cross-priming events.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
B. Strehl, K. Textoris-Taube, S. Jakel, A. Voigt, P. Henklein, U. Steinhoff, P.-M. Kloetzel, and U. Kuckelkorn
Antitopes Define Preferential Proteasomal Cleavage Site Usage
J. Biol. Chem., June 27, 2008; 283(26): 17891 - 17897.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. L. Lin, Y. Zhan, A. I. Proietto, S. Prato, L. Wu, W. R. Heath, J. A. Villadangos, and A. M. Lew
Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset
PNAS, February 26, 2008; 105(8): 3029 - 3034.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.